239 results
PRE 14A
TXMD
TherapeuticsMD Inc
28 Oct 97
Preliminary proxy
12:00am
by the Board of Directors. Any dispute as
to votes or entitlement to vote will be decided by majority vote
of the Board of Directors. Abstentions … and broker non-votes will
not be counted for either quorum or ballot purposes.
As to each item to be voted upon in this Proxy, a numerical
majority
PRER14A
TXMD
TherapeuticsMD Inc
20 Mar 07
Preliminary revised proxy
12:00am
the anticipated majority share approval of the matters set-out in this proxy statement, but in all events not more than 30 days after the anticipated majority … .
Croff Majority Shareholders.
For the purposes of this proxy, the Croff majority common shareholders shall mean and include the common shares held
DEF 14C
xz3l a1rdoh3w70
29 Jun 10
Information statement
12:00am
8-K/A
EX-10.6
wpife2
22 Nov 11
Entry into a Material Definitive Agreement
12:00am
10-K/A
sd6 8nyuwwb
8 Apr 96
Annual report (amended)
12:00am
8-K
EX-99.1
wh7o9x4lh r7oa0f
20 Feb 20
TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results
6:57am
DEFA14A
ix36d r1gb
21 May 21
Additional proxy soliciting materials
5:17pm